Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors
about
Medical treatment for gastro-entero-pancreatic neuroendocrine tumoursPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsDown-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategyAn expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes.GROWTH FACTORS AND COX2 IN WOUND HEALING: AN EXPERIMENTAL STUDY WITH EHRLICH TUMORS.The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers.Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors.Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms.Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene.Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
P2860
Q26751659-07D29323-7D01-407F-B9A7-FD95A5EC98BEQ26862544-B5AC74FD-82B0-4352-9261-2F353E6C8449Q33801805-C2CDBFCC-D07F-49D7-9E32-06F2B844847CQ34978826-35CA0EBA-65E1-4D0A-AD46-2D0F326C0659Q37459597-DC6EE101-F2A2-4593-9E8B-C3A225DB7ECDQ37579476-960911AA-8F44-4FA7-81E9-6B21806D3834Q38755167-9D2743C5-B339-402E-A3E5-DD7E03EC013FQ38928817-C90BFD93-D4A9-42F7-9DD0-0F09486B96E9Q40540183-FC0C56C2-714E-4B04-BF0E-8C85255E7EC6Q40616326-E0D75AC3-7972-48F1-9EC8-683BCDEB1422Q45890813-44973369-BDEF-4DC7-9A11-3331B7B9C991Q52717653-7D408917-46E1-49F1-8731-5875A76DCA41Q52728496-81403A09-C255-4DD4-9B89-5A04141208F4Q53059695-61B2163F-B564-488F-8BBC-E1706053EF32Q58760293-D0A1086F-A1A4-4EEA-AC3F-6E4828E2BFF9
P2860
Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@ast
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@en
type
label
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@ast
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@en
prefLabel
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@ast
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@en
P2860
P1476
Clinical significance of prote ...... ncreatic neuroendocrine tumors
@en
P2093
Hee Sung Kim
Woo Ho Kim
P2860
P304
P356
10.4143/CRT.2011.43.3.181
P577
2011-09-30T00:00:00Z